Review of the management of adverse events associated with Panvax and Fluvax

8.0 References

Page last updated: April 2015

Australian Government Department of Health and Ageing (2008) Australian Health Management Plan for Pandemic Influenza 2008. Canberra, ACT.


Australian Government Department of Health and Ageing (2010) Australian Influenza Surveillance Report No. 44.
Accessed 11 January 2011.

Barlow W. Davis R. Glasser J. et al (2001) The Risk of Seizures after Receipt of Whole-Cell Pertussis or Measles, Mumps, and Rubella Vaccine. N Engl J Med 2345:656-661.

Brighton Collaboration Website (2010) Accessed 24 January 2011.

CDC (2009) Influenza A (H1N1) 2009 Monovalent Vaccine Safety Monitoring: CDC Planning Recommendations for State, Local, Tribal and Territorial Health Officials. Centres for Disease Control and Prevention Website Accessed 25 August 2009

CDC ACIP (2008) Update: Recommendations from the Advisory Committee on Immunization Practices (ACIP) Regarding Administration of Combination MMRV Vaccine. MMWR – Morbidity and Mortality Weekly Report 57(10):258-260.

Chiu S. Tse C. Lau YL. Peiris M. (2001) Influenza A infection is an important cause of febrile seizures. Pediatrics 108(4): e63.

Chung B. Wong V. (2007) Relationship between five common viruses and febrile seizure in children Arch Dis Child 92:589–593.

EMEA (2009) CHMP Recommendations for the Pharmacovigilance Plan as part of the Risk Management Plan to be submitted with the Marketing Authorisation Application for a Pandemic Influenza Vaccine. European Medicines Agency Website Accessed 12 January 2011.

Global Advisory Committee on Vaccine Safety (GAVCS) and WHO Secretariat (2009) Global safety of vaccines: strengthening systems for monitoring, management and the role of GAVCS. Expert Review of Vaccines 8(6):705-716
World Health Organization Website Accessed 18 January 2011.

NHMRC (National Health and Medical Research Council) (2008) The Australian Immunisation Handbook 9th edition. Australian Government Department of Health and Ageing, Canberra ACT.
Department of Health and Ageing Website Accessed 7 January 2011.
Top of Page

NCIRS (2008) Fact Sheet - Influenza Vaccines For Australians: Information For Immunisation Providers Accessed 25 January 2011.

TGA (2010) Suspected adverse reactions to Panvax® reported to the TGA 30 September 2009 to 17 September 2010. Therapeutic Goods Administration Website

TGA (24 September 2010) Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Status report as at 2 July 2010. Updated 24 September 2010. Therapeutic Goods Administration Website

TGA (28 September 2010) Analysis of febrile convulsions following immunisation in children following monovalent pandemic H1N1 vaccine (Panvax®/Panvax Junior®, CSL). Australian Technical Advisory Group on Immunisation (ATAGI) and Therapeutic Goods Administration (TGA) Joint Working Group. Therapeutic Goods Administration Website

TGA (8 October 2010) Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children.
Therapeutic Goods Administration Website

World Health Organization (WHO) (2011) Global Alert and Response, Pandemic Preparedness: What is an influenza pandemic?
World Health Organization Website Accessed 7 March 2011.

World Health Organization (WHO) (2011) Vaccines for pandemic (H1N1) 2009. World Health Organization Website Accessed 21 January 2011.

In this section